Italia markets closed

China Resources Beer (Holdings) Company Limited (0291.HK)

HKSE - HKSE Prezzo differito. Valuta in HKD.
Aggiungi a watchlist
53,750-0,500 (-0,92%)
Alla chiusura: 04:08PM HKT
Schermo intero
Chiusura precedente54,250
Aperto54,200
Denaro53,750 x 0
Lettera53,900 x 0
Min-Max giorno52,800 - 54,950
Intervallo di 52 settimane35,900 - 68,700
Volume11.355.913
Media Volume11.412.514
Capitalizzazione174,365B
Beta (5 anni mensile)0,34
Rapporto PE (ttm)39,23
EPS (ttm)1,370
Prossima data utili17 ago 2022
Rendimento e dividendo (forward)0,62 (1,21%)
Data ex dividendo30 ago 2022
Stima target 1A66,21
  • GlobeNewswire

    Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI)

    Company announcement – No. 4 / 2022 Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI) Top-line results expected in the second quarter of 2022Pending positive results, Zealand intends to file for marketing approval with the US Food and Drug Administration Copenhagen, DK and Boston, MA, U.S. February 15, 2022 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and

  • GlobeNewswire

    Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

    Company announcement – No. 74 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S. December 10, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 5,400 divided into 5,400 new shares with a nominal value of DKK 1 each. The in